Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Sandri

Showing results (151-160 of 186) with videos related to

Pageof 19
Sort By:
Prostate Cancer and Prostatic Diseases|June 21, 2022
The role of preoperative prostatic shape in the recovery of urinary continence after robotic radical prostatectomy: a single cohort analysisV Iacovelli, M Carilli, M Sandri, et al.
Journal of the Royal Society, Interface|January 11, 2013
Magnetic poly(ε-caprolactone)/iron-doped hydroxyapatite nanocomposite substrates for advanced bone tissue engineeringA Gloria, T Russo, U D'Amora, et al.
The Journal of Antimicrobial Chemotherapy|November 27, 2012
Pharmacokinetics of polymyxin B in patients on continuous venovenous haemodialysisAna M Sandri, Cornelia B Landersdorfer, Jovan Jacob, et al.
Journal of Translational Medicine|December 5, 2024
Posterior iliac crest vs. proximal tibia: distinct sources of anti-inflammatory and regenerative cells with comparable 6-month clinical outcomes in treatment of osteoarthritisE Mormone, L Savastano, G Rossi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 24, 2013
Population pharmacokinetics of intravenous polymyxin B in critically ill patients: implications for selection of dosage regimensAna M Sandri, Cornelia B Landersdorfer, Jovan Jacob, et al.
Clinical and Experimental Medicine|June 2, 2005
Interaction between metabolic syndrome and PON1 polymorphisms as a determinant of the risk of coronary artery diseaseN Martinelli, D Girelli, O Olivieri, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 23, 2021
Assessing the predictive performance of population pharmacokinetic models for intravenous polymyxin B in critically ill patientsPatrick O Hanafin, Roger L Nation, Marc H Scheetz, et al.
Msphere|July 14, 2016
ASM Journals Eliminate Impact Factor Information from Journal WebsitesArturo Casadevall, Stefano Bertuzzi, Michael J Buchmeier, et al.
Microbiology and Molecular Biology Reviews : MMBR|July 15, 2016
ASM Journals Eliminate Impact Factor Information from Journal WebsitesArturo Casadevall, Stefano Bertuzzi, Michael J Buchmeier, et al.
Infection and Immunity|July 13, 2016
ASM Journals Eliminate Impact Factor Information from Journal WebsitesArturo Casadevall, Stefano Bertuzzi, Michael J Buchmeier, et al.
Pageof 19

Showing results (151-160 of 186) with videos related to

Sort By:
Pageof 19
Prostate Cancer and Prostatic Diseases|June 21, 2022
The role of preoperative prostatic shape in the recovery of urinary continence after robotic radical prostatectomy: a single cohort analysisV Iacovelli, M Carilli, M Sandri, et al.
Journal of the Royal Society, Interface|January 11, 2013
Magnetic poly(ε-caprolactone)/iron-doped hydroxyapatite nanocomposite substrates for advanced bone tissue engineeringA Gloria, T Russo, U D'Amora, et al.
The Journal of Antimicrobial Chemotherapy|November 27, 2012
Pharmacokinetics of polymyxin B in patients on continuous venovenous haemodialysisAna M Sandri, Cornelia B Landersdorfer, Jovan Jacob, et al.
Journal of Translational Medicine|December 5, 2024
Posterior iliac crest vs. proximal tibia: distinct sources of anti-inflammatory and regenerative cells with comparable 6-month clinical outcomes in treatment of osteoarthritisE Mormone, L Savastano, G Rossi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 24, 2013
Population pharmacokinetics of intravenous polymyxin B in critically ill patients: implications for selection of dosage regimensAna M Sandri, Cornelia B Landersdorfer, Jovan Jacob, et al.
Clinical and Experimental Medicine|June 2, 2005
Interaction between metabolic syndrome and PON1 polymorphisms as a determinant of the risk of coronary artery diseaseN Martinelli, D Girelli, O Olivieri, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 23, 2021
Assessing the predictive performance of population pharmacokinetic models for intravenous polymyxin B in critically ill patientsPatrick O Hanafin, Roger L Nation, Marc H Scheetz, et al.
Msphere|July 14, 2016
ASM Journals Eliminate Impact Factor Information from Journal WebsitesArturo Casadevall, Stefano Bertuzzi, Michael J Buchmeier, et al.
Microbiology and Molecular Biology Reviews : MMBR|July 15, 2016
ASM Journals Eliminate Impact Factor Information from Journal WebsitesArturo Casadevall, Stefano Bertuzzi, Michael J Buchmeier, et al.
Infection and Immunity|July 13, 2016
ASM Journals Eliminate Impact Factor Information from Journal WebsitesArturo Casadevall, Stefano Bertuzzi, Michael J Buchmeier, et al.
Pageof 19